发明名称 CRYSTALLINE FORMS OF 5-(2,6-DI-4-MORPHOLINYL-4-PYRIDMIDINYL)-4-TRIFLUOROMETHYLPYRIDIN-2-AMINE, A PIK3 INHIBITOR
摘要 The invention relates to processes for manufacturing a compound of formula 5, or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of said solid forms for the therapeutic treatment of warm-blooded animals.
申请公布号 EP3040333(A1) 申请公布日期 2016.07.06
申请号 EP20160151719 申请日期 2011.09.29
申请人 NOVARTIS AG 发明人 CALIENNI, JOHN VINCENT;DE LA CRUZ, MARILYN;FLUBACHER, DIETMAR;GONG, BAOQING;KAPA, PRASAD KOTESWARA;KARPINSKI, PIOTR H.;LIU, HUI;MICHEL, PASCAL;MOSE, RASMUS;TESTA, MARIA CATERINA;WAYKOLE, LILADHAR MURLIDHAR
分类号 C07D401/04;A61K31/535;A61P35/00 主分类号 C07D401/04
代理机构 代理人
主权项
地址